Virbac SA Revenue vs. EBITDA
| VIRP Stock | EUR 323.50 4.00 1.25% |
For Virbac SA profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Virbac SA to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Virbac SA utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Virbac SA's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Virbac SA over time as well as its relative position and ranking within its peers.
Virbac |
Virbac SA EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Virbac SA's current stock value. Our valuation model uses many indicators to compare Virbac SA value to that of its competitors to determine the firm's financial worth. Virbac SA is rated first in revenue category among its peers. It is rated first in ebitda category among its peers totaling about 0.19 of EBITDA per Revenue. The ratio of Revenue to EBITDA for Virbac SA is roughly 5.28 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Virbac SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Virbac SA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Virbac Revenue vs. Competition
Virbac SA is rated first in revenue category among its peers. Market size based on revenue of Drug Manufacturers - Major industry is at this time estimated at about 14.79 Billion. Virbac SA holds roughly 1.06 Billion in revenue claiming about 7% of equities under Drug Manufacturers - Major industry.
Virbac EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Virbac SA |
| = | 1.06 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Virbac SA |
| = | 201.66 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Virbac EBITDA Comparison
Virbac SA is currently under evaluation in ebitda category among its peers.
Virbac SA Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Virbac SA, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Virbac SA will eventually generate negative long term returns. The profitability progress is the general direction of Virbac SA's change in net profit over the period of time. It can combine multiple indicators of Virbac SA, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. Virbac SA was founded in 1968 and is headquartered in Carros, France. VIRBAC operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 4893 people.
Virbac Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Virbac SA. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Virbac SA position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Virbac SA's important profitability drivers and their relationship over time.
Use Virbac SA in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Virbac SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virbac SA will appreciate offsetting losses from the drop in the long position's value.Virbac SA Pair Trading
Virbac SA Pair Trading Analysis
The ability to find closely correlated positions to Virbac SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Virbac SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Virbac SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Virbac SA to buy it.
The correlation of Virbac SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Virbac SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Virbac SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Virbac SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Virbac SA position
In addition to having Virbac SA in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Virbac Stock
To fully project Virbac SA's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Virbac SA at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Virbac SA's income statement, its balance sheet, and the statement of cash flows.